Koyfin Home > Directory > Health Care > Aimmune Therap > Other Liabilities

Aimmune Therap Other Liabilities Chart (AIMT)

Aimmune Therap annual/quarterly Other Liabilities from 2014 to 2020.
  • Aimmune Therap Other Liabilities for the quarter ending June 06, 2020 was $2m a 27.94% increase of 0m year over year
  • Aimmune Therap Other Liabilities for the last 12 months ending June 06, 2020 was $2m a 27.94% increase of 0m year over year
  • Aimmune Therap Annual Other Liabilities for 2019 was $1m a -93.96% decrease of -1m from 2018
  • Aimmune Therap Annual Other Liabilities for 2018 was $3m a 0.20% increase of 0m from 2017
  • Aimmune Therap Annual Other Liabilities for 2017 was $3m a 45.97% increase of 1m from 2016
Other Balance Sheet Metrics:
  • Aimmune Therap Total Assets for the quarter ending September 09, 2018 was $287m a 28.01% increase of 81m year over year
  • Aimmune Therap Total Equity for the quarter ending September 09, 2018 was $247m a 28.06% increase of 69m year over year
View Chart On Koyfin

Quarterly AIMT Other Liabilities Data

06/2020$2m
03/2020$1m
12/2019$1m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$3m
09/2018$3m
06/2018$3m
03/2018$2m

Annual AIMT Other Liabilities Data

2019$1m
2018$3m
2017$3m
2016$1m
2015$1m
2014$0m